Searched for
GLENMARK US FDA
Glenmark Pharma shares in focus after USFDA warning to Indore plantGlenmark Pharmaceuticals disclosed receiving a warning letter from the U.S. FDA for its Indore facility following a February inspection. Th...- Glenmark gets USFDA nod to market generic diabetes drugThe company has received final approval from the US Food & Drug Administration (US FDA) for Saxagliptin Tablets (2.5 mg and 5 mg), the gene...
- Glenmark and Cediprof announce exclusive distribution agreement in USGlenmark Pharmaceuticals on Thursday said it has entered into an exclusive agreement with Cediprof Inc for supply and distribution in the U...
- USFDA issues import alert on Glenmark Pharma's Baddi plantThe US Food and Drug Administration inspected the facility in June 2022 and subsequently placed it under "Official Action Indicated" status.
- Glenmark Pharma gets 7 observations from USFDA for Baddi unitGlenmark said its Baddi unit contributes approximately 10 per cent of the revenue of the US sales.
- Glenmark gets US FDA nod for high blood pressure medicineGlenmark’s current portfolio consists of 119 products authorized for distribution in the US and 66 Abbreviated New Drug Approvals (ANDAs) p...
- Glenmark's Ankleshwar plant gets EIR report from USFDA"The EIR is issued by the FDA only if it finds the facility to be deemed acceptable," the company said in a BSE filing.
- Glenmark Pharma gets USFDA nod for two generic drugsQuoting IMS data, Glenmark Pharma said the approved product has an estimated market size of $74.1 million for the 12 months ended November ...
- Dr Reddy's launches insomnia drug in US; Glenmark gets FDA nodThe company has started selling 1 mg, 2 mg and 3 mg tablets of Eszopiclone, a generic version of Lunesta, a sedative drug that is used for ...
- Glenmark recalls three drugs from US marketGlenmark Generics is recalling multiple lots of three of its drugs from the US market due to "odd smell", according to US FDA.
- Glenmark receives ANDA approval for its contraceptive pillsGlenmark Generics Inc., USA, a subsidiary of Glenmark Glenmark on Monday announced they have been granted final approval for their abbrevia...
- Glenmark gets a boost in cholesterol drug battle with MerckGlenmark Pharmaceuticals has gained the upper hand in a legal battle against Merck over a cholesterol control pill after a US court rejecte...
- Glenmark's NDA gets US FDA nodDrug firm Glenmark on Wednesday said US Food and Drug Administration (FDA) has accepted its new drug application (NDA) for pain killer oxyc...
- Glenmark gets first nod for Zetia genericGlenmark Pharmaceuticals has got tentative approval from the USFDA for the generic version of Schering Plough and MSP Singapore Company LLC...
- Glenmark confirms patent challenge of fluticasone lotionGlenmark Generics Ltd's US subsidiary confirmed Nycomed US filed a patent infringement lawsuit on Dec 12, 2008, in the US District Court, E...
- Glenmark to start phase I clinical trials of GBR 500 in USDrug firm Glenmark pharmaceuticals on Friday said it will file an application with American health regulator US Food and Drug Administrator...
- Glenmark confirms Abbott suit against Tarka genericGlenmark Pharmaceuticals has confirmed that Abbott has filed a suit in the US District Court of New Jersey on December 7, seeking to preven...
- Glenmark gets US nod for drug trialsEnding a long wait for Glenmark Pharmaceuticals, the US Food and Drug Administration (FDA) finally gave its nod to the Indian drugmaker to ...
- Glenmark receives FDA nod to market epilepsy drugGlenmark Pharma rose 1.6% to Rs 415 on receiving final approval from the US Food and Drug Administration for marketing Oxcarbazepine tablet...
- Glenmark gets nod to sell Zofran generic in USGlenmark Pharmaceuticals has received final approval to market a generic version of GlaxoSmithKline’s popular anti-emetic drug Zofran, that...
Load More
